Found last Week on the Internet, part 1: Up-to-date Articles on Autoimmunity and Autoimmune Diseases
Duroux-Richard I, Jorgensen C, Apparailly F. miRNAs and rheumatoid arthritis – promising novel biomarkers. Swiss Med Wkly. 2011 Mar 18;141:w13175 – doi: 10.4414/smw.2011.13175 – Free full text available! – Today, the most challenging issue in the field of rheumatoid arthritis is the identification of biomarkers for early disease diagnosis and for prediction drug response. micro(mi)-RNAs certainly represent an realistic option for optimal diagnosis an disease treatment.
Roux CH, Breuil V, Valerio L, Amoretti N, Brocq O, Albert C, Grisot C, Allam Y, Chevalier P, Pradier C, Euller-Ziegler L. Etanercept Compared to Intraarticular Corticosteroid Injection in Rheumatoid Arthritis: Double-blind, Randomized Pilot Study. J Rheumatol. 2011 Mar 16. [Epub ahead of print]. – Patients with rheumatoid arthritis who had persistent (more…)
ACPA in rheumatism diagnostics: new and highly promising biomarkers for rheumatoid arthritis
The diagnosis and treatment of rheumatoid arthritis (RA) have made tremendous progress in the last few years. Experts are even suggesting that a paradigm shift has occurred in the field of rheumatology.
According to rheumatologists, this radical change can be seen in the completely new rheumatoid arthritis medications that have resulted in entirely new treatment options. Again and again, the paradigm shift in rheumatology is attributed to the new possibilities in rheumatoid arthritis diagnostics. Modern RA diagnostics are said to make it increasingly possible for rheumatologists to objectively determine the activity level of RA and thus to predict the progression of this autoimmune disease. (more…)
Recent Publications: Genetic Basis of Psoriasis
It is the nature of things: on days of action like World Psoriasis Day on October 29th of every year) reports about the topic in question and new articles and scientific studies start to pile up.
For example, several research reports on the subject of psoriasis have appeared in the journal Nature Genetics in the last few weeks; as usual, they first appeared online. Whether the approach of World Psoriasis Day was the trigger for this advance publication remains an open question. The results of a Chinese study, a study from the USA and Canada, and a very comprehensive German study all presented in Nature Genetics, which I have linked to below, are generally interesting and newsworthy. (more…)
Biomarkers are the key to prevention and early detection of disease …
… of this I am convinced. And I am firmly convinced that laboratory diagnostics and the use of biomarkers will have a critical effect on the medicine of tomorrow.
Why am I so sure of this? It has already been demonstrated that biomarkers can be used to optimize treatment for individual patients with diabetes. In the future, individualized medicine (also sometimes called “personalized medicine”) will not only significantly increase the efficiency of treatment; it will also greatly improve prevention and early detection. Today it is already possible to carry out a diagnosis in the symptom-free phase of a disease by using biomarkers. This is of great benefit to the patients who receive early and targeted treatment. (more…)
New ACR/EULAR 2010 Classification Criteria for Rheumatoid Arthritis (RA)
European and American rheumatologists have established new criteria for the classification of rheumatoid arthritis (RA). The Revised Classification Criteria for Rheumatoid Arthritis will appear in the September issue of Arthritis & Rheumatism; they can also be viewed online or as a free download at the ACR homepage (accessed 23/08/2010). (more…)
Rheumatoid Arthritis: Some Facts and Figures about this Autoimmune Disorder – and quite a few Weblinks
By posting this article on rheumatoid arthritis, I start building up a glossary on the different types of autoimmune disorders. It will be quite a lot of work creating such an glossary, I’m fully aware of this, and this work has been done many times before by others on other websites and on other blogs.
Not a disease of the elderly: RA often starts between the age of 25 and 55!
But what I have in mind with this “autoimmune disease glossary project” is to exploit you the several mines of information I am using in my job routine, and the abundance of websites I am frequently visiting. In doing so, I start with rheumatoid arthritis, also called RA, as this autoimmune disease is the most common one and the most common inflammatory disease of the joints ever. As a matter of fact 0.5 to 1 percent of the population is affect in “The West” and in other industrialized countries. This means that in Germany about 800,000 individuals are suffering from this autoimmune disorder!
Rheumatoid arthritis, RA, is a form of arthritis. Main symptoms are pain, swelling, stiffness and loss of function in the joints. The disease can affect any joint but it is common in the wrist and fingers. (more…)
Recommendations on the Management of Rheumatoid Arthritis (RA) with DMARDs
A cure for rheumatoid arthritis is not yet possible, that’s fact. However, remission is within one’s reach today.
RA treatment has undergone dramatic changes the last ten years.
Concerning this, an EULAR task force (EULAR is The European League Against Rheumatism) has recently developed and released new RA guidelines for the management of rheumatoid arthritis (RA), based on an systematic literature review.
In these brand new RA recommendations the dramatic developments in therapeutic options in recent years have been recognized as well as the difficulties this has created in defining simple treatment algorithms. The EULAR guidelines can be downloaded free from the EULAR journal Annals of the Rheumatic Diseases free of charge. (more…)
How Bones and the Immune System Do Communicate
The term osteoimmunology was first used about 10 years ago by Joseph R. Arron and Yongwon Choi in their article Osteoimmunology: Bone Versus Immune System in Nature. Since then, a number of articles have appeared in the scientific literature with this term in their title. A Wikipedia article on the subject has also been available since July 2007, though it is only in English and is not (yet) very comprehensive.
There have also been occasional conferences that explicitly included osteoimmunology, for example the 3rd International Conference on Osteoimmunology: Interactions of Immune and Skeletal Systems coming up end of this month in Greece (20-25 June, 2010). In addition, the Deutsche Forschungsgemeinschaft (DFG) has initiated a new area of concentration called Immunobone, in order to promote this area of research and to facilitate networking between the various research groups and numerous different studies. (more…)